Clinical trial · Observational
Quality of Life in Lung Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaires or telephone interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Lung Cancer Survivors
- interventionNames
- Behavioral: questionnaires or telephone interview
Primary outcomes (1)
- measure
- To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- To describe and identify covariates of HQOL in lung cancer survivors.
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of primary Stage IA or IB NSCLC; * Underwent surgical resection for NSCLC at MSKCC; * From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment; * No evidence of disease (NED) at the time of recruitment; * Can be reached by telephone; * Able to provide informed consent. Exclusion Criteria: * Undergoing active antineoplastic treatment; * Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
References
Publications (0)
Data not yet available